Related Experiment Video
Updated: Jun 16, 2025

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
Nuclear PKM2 binds pre-mRNA at folded G-quadruplexes and reveals their gene regulatory role
Dimitrios G Anastasakis1, Maria Apostolidi2, Khalid A Garman3
1RNA Molecular Biology Laboratory, NIAMS/NIH, Bethesda, MD, USA.
Abstract:
Nuclear localization of the metabolic enzyme PKM2 is widely observed in various cancer types. We identify nuclear PKM2 as a non-canonical RNA-binding protein (RBP) that specifically interacts with folded RNA G-quadruplex (rG4) structures in precursor mRNAs (pre-mRNAs). PKM2 occupancy at rG4s prevents the binding of repressive RBPs, such as HNRNPF, and promotes the expression of rG4-containing pre-mRNAs (the "rG4ome"). We observe an upregulation of the rG4ome during epithelial-to-mesenchymal transition and a negative correlation of rG4 abundance with patient survival in different cancer types. By preventing the nuclear accumulation of PKM2, we could repress the rG4ome in triple-negative breast cancer cells and reduce migration and invasion of cancer cells in vitro and in xenograft mouse models. Our data suggest that the balance of folded and unfolded rG4s controlled by RBPs impacts gene expression during tumor progression.
Insights
Nuclear PKM2 binds RNA G-quadruplexes, promoting cancer gene expression. Inhibiting PKM2 reduced cancer cell invasion, suggesting a therapeutic target for cancer progression.
Area of Science:
- Molecular Biology
- Cancer Biology
- RNA Biology
Background:
- Nuclear localization of pyruvate kinase M2 (PKM2) is common in cancers.
- PKM2's role beyond metabolism is increasingly recognized.
Purpose of the Study:
- To investigate the non-canonical functions of nuclear PKM2.
- To determine PKM2's interaction with RNA structures and its role in gene expression.
Main Methods:
- Identifying PKM2 as an RNA-binding protein (RBP).
- Analyzing PKM2's interaction with RNA G-quadruplex (rG4) structures in pre-mRNAs.
- Assessing the impact of PKM2 on the expression of rG4-containing pre-mRNAs (the "rG4ome").
- Evaluating the role of PKM2 and the rG4ome in cancer progression, including epithelial-to-mesenchymal transition (EMT) and patient survival.
- Investigating the therapeutic potential of inhibiting nuclear PKM2 accumulation in triple-negative breast cancer (TNBC) models.
Main Results:
- Nuclear PKM2 functions as an RBP that specifically binds to folded RNA G-quadruplex (rG4) structures in pre-mRNAs.
- PKM2 binding to rG4s displaces repressive RBPs (e.g., HNRNPF), thereby promoting the expression of rG4-containing pre-mRNAs (the "rG4ome").
- The rG4ome is upregulated during EMT, and higher rG4 abundance correlates with poorer patient survival across various cancer types.
- Inhibition of nuclear PKM2 accumulation suppressed the rG4ome in TNBC cells, reducing cancer cell migration and invasion in vitro and in vivo.
Conclusions:
- Nuclear PKM2 is a key regulator of the rG4ome, influencing gene expression during tumor progression.
- The balance between folded and unfolded rG4 structures, modulated by RBPs like PKM2, is critical for cancer development.
- Targeting nuclear PKM2 offers a potential therapeutic strategy to combat cancer by repressing the rG4ome and inhibiting cancer cell invasion.
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
Regulation of Nuclear Protein Sorting
RNA Polymerase II Accessory Proteins
Cooperative Binding of Transcription Regulators

